FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 69 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,293,000 | +169.2% | 152,186 | 0.0% | 0.12% | +227.0% |
| Q2 2021 | $1,595,000 | +62.1% | 152,186 | +82.1% | 0.04% | +68.2% |
| Q1 2021 | $984,000 | +0.6% | 83,550 | 0.0% | 0.02% | 0.0% |
| Q4 2020 | $978,000 | +47.5% | 83,550 | 0.0% | 0.02% | +37.5% |
| Q3 2020 | $663,000 | -56.6% | 83,550 | 0.0% | 0.02% | -54.3% |
| Q2 2020 | $1,528,000 | +33.9% | 83,550 | -12.5% | 0.04% | +20.7% |
| Q1 2020 | $1,141,000 | -50.6% | 95,533 | -31.2% | 0.03% | -37.0% |
| Q4 2019 | $2,309,000 | +363.7% | 138,767 | +85.0% | 0.05% | +318.2% |
| Q3 2019 | $498,000 | – | 75,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |